HEADER TRANSFERASE 20-OCT-22 8H7F TITLE THE CRYSTAL STRUCTURE OF HUMAN ABL1 KINASE DOMAIN IN COMPLEX WITH TITLE 2 ABL1-B-EBA COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS COMPLEX, INHIBITOR, LYSINE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.J.ZHU,Z.M.ZHANG REVDAT 2 07-FEB-24 8H7F 1 REMARK REVDAT 1 01-MAR-23 8H7F 0 JRNL AUTH P.CHEN,G.TANG,C.ZHU,J.SUN,X.WANG,M.XIANG,H.HUANG,W.WANG, JRNL AUTH 2 L.LI,Z.M.ZHANG,L.GAO,S.Q.YAO JRNL TITL 2-ETHYNYLBENZALDEHYDE-BASED, LYSINE-TARGETING IRREVERSIBLE JRNL TITL 2 COVALENT INHIBITORS FOR PROTEIN KINASES AND NONKINASES. JRNL REF J.AM.CHEM.SOC. 2023 JRNL REFN ESSN 1520-5126 JRNL PMID 36774655 JRNL DOI 10.1021/JACS.2C11595 REMARK 2 REMARK 2 RESOLUTION. 2.45 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.9_1692+SVN REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.45 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 42.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.338 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 29696 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.234 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 6.725 REMARK 3 FREE R VALUE TEST SET COUNT : 1997 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 42.9800 - 5.9004 1.00 2138 153 0.1952 0.2113 REMARK 3 2 5.9004 - 4.6852 1.00 2017 147 0.1872 0.2174 REMARK 3 3 4.6852 - 4.0935 1.00 2008 144 0.1753 0.1854 REMARK 3 4 4.0935 - 3.7194 1.00 1986 143 0.1920 0.1987 REMARK 3 5 3.7194 - 3.4530 1.00 1994 142 0.1957 0.2519 REMARK 3 6 3.4530 - 3.2495 1.00 1969 143 0.2064 0.2692 REMARK 3 7 3.2495 - 3.0868 1.00 1956 140 0.2131 0.2156 REMARK 3 8 3.0868 - 2.9524 1.00 1958 142 0.2189 0.2537 REMARK 3 9 2.9524 - 2.8388 1.00 1947 141 0.2260 0.2843 REMARK 3 10 2.8388 - 2.7409 1.00 1973 142 0.2209 0.2897 REMARK 3 11 2.7409 - 2.6552 1.00 1934 140 0.2335 0.2548 REMARK 3 12 2.6552 - 2.5793 1.00 1937 139 0.2357 0.2628 REMARK 3 13 2.5793 - 2.5114 1.00 1962 142 0.2373 0.3208 REMARK 3 14 2.5114 - 2.4502 1.00 1920 139 0.2431 0.2815 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.250 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 23.466 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 39.84 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 4359 REMARK 3 ANGLE : 0.684 5921 REMARK 3 CHIRALITY : 0.026 629 REMARK 3 PLANARITY : 0.003 740 REMARK 3 DIHEDRAL : 13.484 1560 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8H7F COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 26-OCT-22. REMARK 100 THE DEPOSITION ID IS D_1300032979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 04-SEP-22 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL02U1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-3000 REMARK 200 DATA SCALING SOFTWARE : XIA2 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 46218 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.120 REMARK 200 RESOLUTION RANGE LOW (A) : 52.250 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 13.30 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 9.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.12 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.20 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 7W7Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.46 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.5M (NH4)2 SO4, 0.1M HEPES (PH 7.0) REMARK 280 AND 4% V/V 1,3-PROPANEDIOL., VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 2 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 X,-Y,-Z REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 -X,-Y+1/2,Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.48800 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 66.24350 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.48800 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 66.24350 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLY A 224 REMARK 465 ALA A 225 REMARK 465 MET A 226 REMARK 465 GLY A 227 REMARK 465 SER A 228 REMARK 465 SER A 229 REMARK 465 PRO A 230 REMARK 465 ASN A 231 REMARK 465 LYS A 274 REMARK 465 GLU A 275 REMARK 465 GLY B 224 REMARK 465 ALA B 225 REMARK 465 MET B 226 REMARK 465 GLY B 227 REMARK 465 SER B 228 REMARK 465 SER B 229 REMARK 465 PRO B 230 REMARK 465 ASN B 231 REMARK 465 TYR B 232 REMARK 465 LYS B 274 REMARK 465 GLU B 275 REMARK 465 ASP B 276 REMARK 465 THR B 277 REMARK 465 MET B 278 REMARK 465 THR B 306 REMARK 465 ARG B 307 REMARK 465 GLU B 308 REMARK 465 PRO B 309 REMARK 465 PRO B 310 REMARK 465 PHE B 311 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 TYR A 232 CG CD1 CD2 CE1 CE2 CZ OH REMARK 470 ASP A 233 CG OD1 OD2 REMARK 470 LYS A 234 CG CD CE NZ REMARK 470 ARG A 239 CG CD NE CZ NH1 NH2 REMARK 470 ASP A 276 CG OD1 OD2 REMARK 470 THR A 277 OG1 CG2 REMARK 470 GLU A 308 CG CD OE1 OE2 REMARK 470 GLU A 334 CG CD OE1 OE2 REMARK 470 ASP A 444 CG OD1 OD2 REMARK 470 ASP B 233 CG OD1 OD2 REMARK 470 LYS B 234 CG CD CE NZ REMARK 470 MET B 237 CG SD CE REMARK 470 GLU B 238 CG CD OE1 OE2 REMARK 470 ARG B 239 CG CD NE CZ NH1 NH2 REMARK 470 LYS B 245 CG CD CE NZ REMARK 470 HIS B 246 CG ND1 CD2 CE1 NE2 REMARK 470 LYS B 247 CG CD CE NZ REMARK 470 LYS B 262 CG CD CE NZ REMARK 470 LYS B 263 CG CD CE NZ REMARK 470 GLU B 281 CG CD OE1 OE2 REMARK 470 LYS B 400 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O TYR B 449 O HOH B 701 1.98 REMARK 500 OE2 GLU B 279 O HOH B 702 2.03 REMARK 500 OE2 GLU B 334 O HOH B 703 2.17 REMARK 500 OE1 GLU A 329 O HOH A 701 2.17 REMARK 500 O ILE B 293 O HOH B 704 2.18 REMARK 500 O ASN B 374 O HOH B 705 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LYS A 245 -135.45 -114.43 REMARK 500 THR A 277 -144.07 55.61 REMARK 500 ARG A 307 -32.88 -130.90 REMARK 500 ASP A 363 45.47 -151.50 REMARK 500 PRO A 402 91.65 -68.85 REMARK 500 TYR A 440 60.57 39.60 REMARK 500 LYS B 245 -144.58 -131.70 REMARK 500 ASN B 336 -160.45 -102.51 REMARK 500 ASP B 363 50.11 -149.52 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 781 DISTANCE = 6.03 ANGSTROMS REMARK 525 HOH B 782 DISTANCE = 6.11 ANGSTROMS REMARK 525 HOH B 783 DISTANCE = 6.15 ANGSTROMS DBREF 8H7F A 229 500 UNP P00519 ABL1_HUMAN 229 500 DBREF 8H7F B 229 500 UNP P00519 ABL1_HUMAN 229 500 SEQADV 8H7F GLY A 224 UNP P00519 EXPRESSION TAG SEQADV 8H7F ALA A 225 UNP P00519 EXPRESSION TAG SEQADV 8H7F MET A 226 UNP P00519 EXPRESSION TAG SEQADV 8H7F GLY A 227 UNP P00519 EXPRESSION TAG SEQADV 8H7F SER A 228 UNP P00519 EXPRESSION TAG SEQADV 8H7F GLY B 224 UNP P00519 EXPRESSION TAG SEQADV 8H7F ALA B 225 UNP P00519 EXPRESSION TAG SEQADV 8H7F MET B 226 UNP P00519 EXPRESSION TAG SEQADV 8H7F GLY B 227 UNP P00519 EXPRESSION TAG SEQADV 8H7F SER B 228 UNP P00519 EXPRESSION TAG SEQRES 1 A 277 GLY ALA MET GLY SER SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 A 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 A 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 A 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 A 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 A 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 A 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 A 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 A 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 A 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 A 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 A 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 A 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 A 277 PTR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 A 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 A 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 A 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 A 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 A 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 A 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 A 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 A 277 PHE GLN GLU SER SEQRES 1 B 277 GLY ALA MET GLY SER SER PRO ASN TYR ASP LYS TRP GLU SEQRES 2 B 277 MET GLU ARG THR ASP ILE THR MET LYS HIS LYS LEU GLY SEQRES 3 B 277 GLY GLY GLN TYR GLY GLU VAL TYR GLU GLY VAL TRP LYS SEQRES 4 B 277 LYS TYR SER LEU THR VAL ALA VAL LYS THR LEU LYS GLU SEQRES 5 B 277 ASP THR MET GLU VAL GLU GLU PHE LEU LYS GLU ALA ALA SEQRES 6 B 277 VAL MET LYS GLU ILE LYS HIS PRO ASN LEU VAL GLN LEU SEQRES 7 B 277 LEU GLY VAL CYS THR ARG GLU PRO PRO PHE TYR ILE ILE SEQRES 8 B 277 THR GLU PHE MET THR TYR GLY ASN LEU LEU ASP TYR LEU SEQRES 9 B 277 ARG GLU CYS ASN ARG GLN GLU VAL ASN ALA VAL VAL LEU SEQRES 10 B 277 LEU TYR MET ALA THR GLN ILE SER SER ALA MET GLU TYR SEQRES 11 B 277 LEU GLU LYS LYS ASN PHE ILE HIS ARG ASP LEU ALA ALA SEQRES 12 B 277 ARG ASN CYS LEU VAL GLY GLU ASN HIS LEU VAL LYS VAL SEQRES 13 B 277 ALA ASP PHE GLY LEU SER ARG LEU MET THR GLY ASP THR SEQRES 14 B 277 PTR THR ALA HIS ALA GLY ALA LYS PHE PRO ILE LYS TRP SEQRES 15 B 277 THR ALA PRO GLU SER LEU ALA TYR ASN LYS PHE SER ILE SEQRES 16 B 277 LYS SER ASP VAL TRP ALA PHE GLY VAL LEU LEU TRP GLU SEQRES 17 B 277 ILE ALA THR TYR GLY MET SER PRO TYR PRO GLY ILE ASP SEQRES 18 B 277 LEU SER GLN VAL TYR GLU LEU LEU GLU LYS ASP TYR ARG SEQRES 19 B 277 MET GLU ARG PRO GLU GLY CYS PRO GLU LYS VAL TYR GLU SEQRES 20 B 277 LEU MET ARG ALA CYS TRP GLN TRP ASN PRO SER ASP ARG SEQRES 21 B 277 PRO SER PHE ALA GLU ILE HIS GLN ALA PHE GLU THR MET SEQRES 22 B 277 PHE GLN GLU SER MODRES 8H7F PTR A 393 TYR MODIFIED RESIDUE MODRES 8H7F PTR B 393 TYR MODIFIED RESIDUE HET PTR A 393 16 HET PTR B 393 16 HET QEW A 601 28 HET QEW B 601 28 HETNAM PTR O-PHOSPHOTYROSINE HETNAM QEW 1-[6-(6-METHOXYISOQUINOLIN-7-YL)-1,3-BENZOTHIAZOL-2- HETNAM 2 QEW YL]-3-(2-OXIDANYLIDENEETHYL)UREA HETSYN PTR PHOSPHONOTYROSINE FORMUL 1 PTR 2(C9 H12 N O6 P) FORMUL 3 QEW 2(C20 H16 N4 O3 S) FORMUL 5 HOH *195(H2 O) HELIX 1 AA1 GLU A 238 THR A 240 5 3 HELIX 2 AA2 GLY A 249 GLN A 252 5 4 HELIX 3 AA3 LYS A 263 SER A 265 5 3 HELIX 4 AA4 GLU A 279 LYS A 291 1 13 HELIX 5 AA5 LEU A 323 CYS A 330 1 8 HELIX 6 AA6 ASN A 336 LYS A 357 1 22 HELIX 7 AA7 ALA A 365 ARG A 367 5 3 HELIX 8 AA8 GLU A 373 HIS A 375 5 3 HELIX 9 AA9 PRO A 402 THR A 406 5 5 HELIX 10 AB1 ALA A 407 ASN A 414 1 8 HELIX 11 AB2 SER A 417 THR A 434 1 18 HELIX 12 AB3 ASP A 444 SER A 446 5 3 HELIX 13 AB4 GLN A 447 LYS A 454 1 8 HELIX 14 AB5 PRO A 465 TRP A 476 1 12 HELIX 15 AB6 ASN A 479 ARG A 483 5 5 HELIX 16 AB7 SER A 485 GLU A 499 1 15 HELIX 17 AB8 VAL B 280 ILE B 293 1 14 HELIX 18 AB9 LEU B 323 CYS B 330 1 8 HELIX 19 AC1 ASN B 336 LYS B 357 1 22 HELIX 20 AC2 ALA B 365 ARG B 367 5 3 HELIX 21 AC3 GLU B 373 HIS B 375 5 3 HELIX 22 AC4 PRO B 402 THR B 406 5 5 HELIX 23 AC5 ALA B 407 ASN B 414 1 8 HELIX 24 AC6 SER B 417 THR B 434 1 18 HELIX 25 AC7 ASP B 444 GLN B 447 5 4 HELIX 26 AC8 VAL B 448 LYS B 454 1 7 HELIX 27 AC9 PRO B 465 TRP B 476 1 12 HELIX 28 AD1 ASN B 479 ARG B 483 5 5 HELIX 29 AD2 SER B 485 GLU B 499 1 15 SHEET 1 AA1 5 ILE A 242 LYS A 247 0 SHEET 2 AA1 5 VAL A 256 TRP A 261 -1 O GLU A 258 N HIS A 246 SHEET 3 AA1 5 LEU A 266 THR A 272 -1 O LEU A 266 N TRP A 261 SHEET 4 AA1 5 TYR A 312 GLU A 316 -1 O ILE A 313 N LYS A 271 SHEET 5 AA1 5 LEU A 301 CYS A 305 -1 N LEU A 302 O ILE A 314 SHEET 1 AA2 3 GLY A 321 ASN A 322 0 SHEET 2 AA2 3 CYS A 369 VAL A 371 -1 O VAL A 371 N GLY A 321 SHEET 3 AA2 3 VAL A 377 VAL A 379 -1 O LYS A 378 N LEU A 370 SHEET 1 AA3 2 PHE A 359 ILE A 360 0 SHEET 2 AA3 2 SER A 385 ARG A 386 -1 O SER A 385 N ILE A 360 SHEET 1 AA4 2 PTR A 393 THR A 394 0 SHEET 2 AA4 2 LYS A 415 PHE A 416 -1 O PHE A 416 N PTR A 393 SHEET 1 AA5 4 VAL B 256 TRP B 261 0 SHEET 2 AA5 4 LEU B 266 LYS B 271 -1 O VAL B 268 N GLY B 259 SHEET 3 AA5 4 ILE B 313 GLU B 316 -1 O ILE B 313 N LYS B 271 SHEET 4 AA5 4 LEU B 301 GLY B 303 -1 N LEU B 302 O ILE B 314 SHEET 1 AA6 3 GLY B 321 ASN B 322 0 SHEET 2 AA6 3 CYS B 369 VAL B 371 -1 O VAL B 371 N GLY B 321 SHEET 3 AA6 3 VAL B 377 VAL B 379 -1 O LYS B 378 N LEU B 370 SHEET 1 AA7 2 PHE B 359 HIS B 361 0 SHEET 2 AA7 2 LEU B 384 ARG B 386 -1 O SER B 385 N ILE B 360 SHEET 1 AA8 2 PTR B 393 THR B 394 0 SHEET 2 AA8 2 LYS B 415 PHE B 416 -1 O PHE B 416 N PTR B 393 LINK CE LYS A 271 N1 QEW A 601 1555 1555 1.50 LINK C THR A 392 N PTR A 393 1555 1555 1.33 LINK C PTR A 393 N THR A 394 1555 1555 1.33 LINK CE LYS B 271 N1 QEW B 601 1555 1555 1.50 LINK C THR B 392 N PTR B 393 1555 1555 1.33 LINK C PTR B 393 N THR B 394 1555 1555 1.33 CISPEP 1 PRO A 309 PRO A 310 0 -1.63 CRYST1 56.502 104.976 132.487 90.00 90.00 90.00 P 2 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.017699 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009526 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007548 0.00000